STOCK TITAN

LKYSF - $LKYSF STOCK NEWS

Welcome to our dedicated page for LKYSF news (Ticker: $LKYSF), a resource for investors and traders seeking the latest updates and insights on LKYSF stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LKYSF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LKYSF's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
LKYSF

OTC:LKYSF

LKYSF Rankings

LKYSF Stock Data

0
191.64M
Medical/Nursing Services
Health Services
Link
CA
Vancouver

About LKYSF

Numinus Wellness, Inc. is a health care company that operates a testing and research facility that can support the emerging market of psychedelic therapies to supplement existing options in addressing mental illness, addictions, and post-traumatic stress disorder. Through its subsidiary, it tests and analyzes cannabis products from licensed producers. It also allows to test, possess, buy, and sell MDMA, psilocybin, psilocin, DMT and mescaline. The company was founded by Payton Nyquvest and Stacey Wallin on June 26, 1962 and is headquartered in Vancouver, Canada.